AstraZeneca Withdraws Drug for Hairy Cell Leukemia From US Market ...Middle East

Medscape - News
The company is planning to remove its leukemia drug moxetumomab pasudotox-tdfk (Lumoxiti) from the US market, saying there has been 'very low clinical uptake' of the product. Medscape Medical News

Hence then, the article about astrazeneca withdraws drug for hairy cell leukemia from us market was published today ( ) and is available on Medscape ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( AstraZeneca Withdraws Drug for Hairy Cell Leukemia From US Market )

Apple Storegoogle play

Last updated :

Also on site :



Latest News